Audientes A/S: Q3 2024 Financial Report
Reading Time: 4 minutes Company announcement no. 33-2024November 21, 2024 Audientes A/S (“Audientes” or the “Company”), CVR 36047631, announces its unaudited financial results for Q3 2024. The Company provides updates on progress in its key markets and adjusts its sales and financial objectives for the
Tele2 announces changes to the Group Leadership Team
Reading Time: 2 minutes Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) announces that Yogesh Malik, Executive Vice President and CTIO, will step down from his position effective from today. Yogesh joined Tele2 and the Group Leadership Team in April
Fondia Plc: Share repurchase 21.11.2024
Reading Time: < 1 minute Fondia Plc Company release 21.11.2024 at 6.45 p.m. EET Fondia – Acquisition of own shares 21.11.2024 Fondia Plc First North Finland Date 21.11.2024 Exchange transactions Buy Share class FONDIA Amount, shares 323 Average price/share, EUR 5,90
ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 21.11.2024
Reading Time: < 1 minute ALEXANDRIA GROUP OYJ NOTIFICATION 21.11.2024 at 18:30 EET ALEXANDRIA GROUP OYJ: ACQUISITION OF OWN SHARES 21.11.2024 Date 21.11.2024 Exchange transaction Buy Share class ALEX Amount 210 Average price/share 8.6500 EUR Highest
#24-119 ECOMB AB approved for listing at NGM
Reading Time: < 1 minute Nordic Growth Market NGM AB (“NGM“) has, as previously announced, decided to list the shares in ECOMB AB at NGM. The first day of trading has been set to November 25, 2024. The shares in ECOMB AB have
CasinoRank Explores iGaming Regulation Changes and Their Impact
Reading Time: 2 minutes November 21, 2024 — CasinoRank, a trusted authority in online casino industry, provides insights on regulatory changes shaping the global iGaming market. These changes, spanning multiple jurisdictions, are redefining the landscape for operators, players, and stakeholders worldwide. While many regions
Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion
Reading Time: 2 minutes Oslo, November 21st 2024: Lytix Biopharma refers to the release made today by its licensing partner Verrica Pharmaceuticals, announcing the pricing of a USD 42 million underwritten public offering. The offering is expected to close on November 22, 2024, and the
WNS Recognized as a Leader in Supply Chain by ISG
Reading Time: 3 minutes London, United Kingdom & New York, United States & Mumbai, Maharashtra, India: WNS (Holdings) Limited (NYSE: WNS), a digital-led business transformation and services partner, today announced that it has been recognized as a ‘Leader’ in Supply Chain BPO Services by ISG
Monitra Health Announces Grant of U.S. Patent for Advanced Wireless Cardiac Monitoring Technology
Reading Time: 3 minutes Monitra Healthcare Private Limited, a pioneer in health monitoring technologies, proudly announces the grant of its U.S. Patent No. 12,109,029 B2, titled Wireless Cardiac Monitoring Device and Method to Measure and Transmit Cardiac Physiological Signals. This patent, issued by the United States Patent and Trademark
Royalti Achieves an Unprecedented 200 Crores Sales at Oberoi Garden City Launch
Reading Time: 2 minutes Royalti, a distinguished real estate consulting firm in the high-end and luxury market has set a new benchmark by grossing over Rs. 200 crores in sales at the recent launch of Oberoi Garden City (OGC) on Pokhran Road 2, Thane. This exceptional achievement, recorded within